Stents Drug Eluting

This channel includes news and new technology innovations for drug eluting stents (DES). These drug coated stents were developed to solve a frequent problem with bare metal stents, which can cause neointimal hyperplasia (scar tissue growth) in some patients. The antiproliferative drugs used on DES prevent the growth of tissue. One downside of DES is the requirement for patients to take long-term antiplatelet therapy to prevent the possible formation of clots on these stents. Newer generation DES use technologies help the vessels heal faster, which may allow reduce the duration of dual antiplatelet therapy (DAPT), or use a single drug, usually eliminating aspirin. This section includes news for both metallic and bioresorbable drug-eluting stents and related clinical trial data.

News | January 24, 2011

January 24, 2011 – Patient enrollment was completed in the EVOLVE clinical trial, which is designed to assess the...

News | January 21, 2011

January 20, 2011 – European CE mark approval was granted to expand the indication of Abbott’s Xience Prime...

News | October 10, 2011

January 20, 2011 – Drug-coated stents hold promise as a safe and lasting solution for the treatment of clogged leg...

Feature | January 10, 2011

January 10, 2011 – European CE mark approval was announced today for the Abbott, Absorb drug-eluting bioresorbable...

News | December 06, 2010

December 6, 2010 - A European court has struck a blow to Boston Scientific's alleged patent infringement case...

News | September 28, 2010

September 28, 2010 – Three-year follow-up data from the HORIZONS-AMI trial presented at Transcatheter Cardiovascular...

News | September 24, 2010

September 24, 2010 – Drug-eluting stents are beneficial in treating symptomatic peripheral artery disease (...

News | September 24, 2010

September 24, 2010 - Two-year data from the SPIRIT IV trial show that everolimus-eluting stents...

News | September 23, 2010

September 23, 2010 - Results from the second stage of a trial studying a bioresorbable vascular scaffold were...

News | September 23, 2010

September 23, 2010 - Results from a study evaluating the safety and clinical efficacy of the Promus Element...

News | September 22, 2010

September 22, 2010 – Coronary artery disease, a leading cause of death and poor quality of life worldwide,...

News | September 21, 2010

September 21, 2010 – A new drug-eluting stent system has received CE mark approval for diabetic patients...

News | September 20, 2010

September 20, 2010 – Patient enrollment has started in the EXCELLA BD Randomized Clinical Trial designed to evaluate...

News | September 14, 2010

September 14, 2010 – The latest clinical trial data for the Promus Element and Taxus Element coronary...

News | September 08, 2010

September 8. 2010 – Intravascular ultrasound (IVUS)-guided bifurcation stenting significantly reduced the...

Overlay Init